BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND ATIC, IMPCHASE, 471, ENSG00000138363, AICARFT, P31939, PURH AND Treatment
48 results:

  • 1. Cancer Risk in Graves Disease with Radioactive
    Kim KJ; Choi J; Kim KJ; Song E; Yu JH; Kim NH; Yoo HJ; Seo JA; Kim NH; Choi KM; Baik SH; Kim SG
    J Nucl Med; 2024 May; 65(5):693-699. PubMed ID: 38548348
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell Neoplasms.
    Liu Y; Ho C; Yu W; Huang Y; Miller J; Gao Q; Syed M; Ma Y; Wang M; Maciag L; Petrova-Drus K; Zhu M; Yao J; Vanderbilt C; Durham B; Benhamida J; Ewalt MD; Dogan A; Roshal M; Nafa K; Arcila ME
    J Mol Diagn; 2024 Mar; 26(3):168-178. PubMed ID: 38103591
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic leukemia Relapsing after First-Line treatment with Fixed-Duration Ibrutinib plus Venetoclax.
    Jain N; Croner LJ; Allan JN; Siddiqi T; Tedeschi A; Badoux XC; Eckert K; Cheung LWK; Mukherjee A; Dean JP; Szafer-Glusman E; Seymour JF
    Clin Cancer Res; 2024 Feb; 30(3):498-505. PubMed ID: 37955424
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Causes of death and treatment-related mortality in newly diagnosed childhood acute lymphoblastic leukemia treatment with Chinese Children's Cancer Group study ALL-2015.
    Liu K; Shao J; Cai J; Tang J; Shen S; Xu F; Ren Y; Zhang A; Tian X; Lu X; Hu S; Hu Q; Jiang H; Zhou F; Liang C; Leung AWK; Zhai X; Li C; Fang Y; Wang Z; Wen L; Yang H; Wang N; Jiang H
    Ann Hematol; 2023 Dec; 102(12):3431-3444. PubMed ID: 37550503
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Economic and Social Burden of Childhood Cancer in Bangladesh.
    Rahman SA; Variyath S; Al-Yateem N; Al Marzouqi A; Subu MA
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):69-74. PubMed ID: 36708553
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Chilblain-like lesions coinciding with the SARS-CoV-2 pandemic.
    Starkey SY; Mar K; Kashetsky N; Lam JM; Dutz J; Mukovozov I
    Clin Dermatol; 2023; 41(1):223-229. PubMed ID: 36228990
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Molecular and Pharmacological Bladder Cancer Therapy Screening: Discovery of Clofarabine as a Highly Active Compound.
    Ertl IE; Lemberger U; Ilijazi D; Hassler MR; Bruchbacher A; Brettner R; Kronabitter H; Gutmann M; Vician P; Zeitler G; Koren A; Lardeau CH; Mohr T; Haitel A; Compérat E; Oszwald A; Wasinger G; Clozel T; Elemento O; Kubicek S; Berger W; Shariat SF
    Eur Urol; 2022 Sep; 82(3):261-270. PubMed ID: 35393162
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. treatment Pattern, Financial Burden, and Outcomes in Elderly Patients with Acute Myeloid leukemia in Korea: A Nationwide Cohort Study.
    Ha H; Jeong Y; Lim JH; Suh YJ
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206499
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of Variants in the
    Cereja Pantoja KBC; Azevedo TCB; Carvalho DC; Monte N; Cohen Paes AN; Barros MCDC; Vinagre LWMS; Freitas ARS; Burbano RMR; Assumpção PP; Santos SEBD; Fernandes MR; Santos NPCD
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205374
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic leukemia: A Randomized Clinical Trial.
    Brown PA; Ji L; Xu X; Devidas M; Hogan LE; Borowitz MJ; Raetz EA; Zugmaier G; Sharon E; Bernhardt MB; Terezakis SA; Gore L; Whitlock JA; Pulsipher MA; Hunger SP; Loh ML
    JAMA; 2021 Mar; 325(9):833-842. PubMed ID: 33651090
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. DNA-thioguanine nucleotide as a treatment marker in acute lymphoblastic leukemia patients with NUDT15 variant genotypes.
    Ju HY; Lee JW; Cho HW; Hyun JK; Ma Y; Yi ES; Yoo KH; Sung KW; Choi R; Koo HH; Lee SY
    PLoS One; 2021; 16(1):e0245667. PubMed ID: 33481917
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comparison Between Venetoclax-based and Bruton Tyrosine Kinase Inhibitor-based Therapy as Upfront treatment of Chronic Lymphocytic leukemia (CLL): A Systematic Review and Network Meta-analysis.
    Molica S; Giannarelli D; Montserrat E
    Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):216-223. PubMed ID: 33199185
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Health Care Cost Associated With Contemporary Chronic Myelogenous leukemia Therapy Compared With That of Other Hematologic Malignancies.
    Wilkes JJ; Lyman GH; Doody DR; Chennupati S; Becker LK; Morin PE; Winestone LE; Henk HJ; Chow EJ
    JCO Oncol Pract; 2021 Mar; 17(3):e406-e415. PubMed ID: 32822255
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review.
    Zhu J; Yang Y; Tao J; Wang SL; Chen B; Dai JR; Hu C; Qi SN; Li YX
    Leukemia; 2020 Oct; 34(10):2576-2591. PubMed ID: 32651542
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Recurrent episodes of hypothermia as a sequela of human herpesvirus 6 encephalitis following cord blood transplantation for acute myeloid leukemia].
    Sakoh T; Taya Y; Hirayama T; Oba Y; Mitsuki T; Nishida A; Ishiwata K; Watanabe C; Wake A
    Rinsho Ketsueki; 2020; 61(3):274-279. PubMed ID: 32224590
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Association between C1236T Genetic Variant of ABCB1 Gene and Molecular Response to Imatinib in Indonesian Chronic Myeloid Patients.
    Rinaldi I; Nova R; Widyastuti R; Priambodo R; Instiaty I; Louisa M
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3331-3334. PubMed ID: 31759356
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Long-Term Follow-Up of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Treated in the HD7 to HD15 Trials: A Report From the German Hodgkin Study Group.
    Eichenauer DA; Plütschow A; Fuchs M; Sasse S; Baues C; Böll B; von Tresckow B; Diehl V; Borchmann P; Engert A
    J Clin Oncol; 2020 Mar; 38(7):698-705. PubMed ID: 31626571
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based study.
    Kizilors A; Crisà E; Lea N; Passera R; Mian S; Anwar J; Best S; Nicolini FE; Ireland R; Aldouri M; Pocock C; Corbett T; Gale R; Bart-Smith E; Weston-Smith S; Wykes C; Kulasekararaj A; Jackson S; Harrington P; McLornan D; Raj K; Pagliuca A; Mufti GJ; de Lavallade H
    Lancet Haematol; 2019 May; 6(5):e276-e284. PubMed ID: 31036317
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Pathway genes and metabolites in thiopurine therapy in Korean children with acute lymphoblastic leukaemia.
    Choi R; Sohn I; Kim MJ; Woo HI; Lee JW; Ma Y; Yi ES; Koo HH; Lee SY
    Br J Clin Pharmacol; 2019 Jul; 85(7):1585-1597. PubMed ID: 30927276
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Clinical characteristics and prognosis of 34 cases of acute myeloid leukemia with FLT3 internal tandem duplication and MLL gene rearrangement].
    Zhou JR; Zhang X; Zhao YL; Yang JF; Zhang JP; Cao XY; Lu Y; Liu DY; Lyu FY; Ouyang J; Lu PH
    Zhonghua Xue Ye Xue Za Zhi; 2018 Sep; 39(9):751-756. PubMed ID: 30369187
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 3.